标题/作者	年份
Cytokine storm in COVID-19: the current evidence and treatment strategies Y Tang, J Liu, D Zhang, Z Xu, J Ji, C Wen Frontiers in immunology 11, 1708	2020
COVID-19 infection and rheumatoid arthritis: Faraway, so close! EG Favalli, F Ingegnoli, O De Lucia, G Cincinelli, R Cimaz, R Caporali Autoimmunity reviews 19 (5), 102523	2020
Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis SR Ytterberg, DL Bhatt, TR Mikuls, GG Koch, R Fleischmann, JL Rivas, ... New England Journal of Medicine 386 (4), 316-326	2022
Translating IL-6 biology into effective treatments EH Choy, F De Benedetti, T Takeuchi, M Hashizume, MR John, ... Nature Reviews Rheumatology 16 (6), 335-345	2020
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis A Sepriano, A Kerschbaumer, JS Smolen, D Van Der Heijde, ... Annals of the rheumatic diseases 79 (6), 760-770	2020
EULAR definition of difficult-to-treat rheumatoid arthritis G Nagy, NMT Roodenrijs, PMJ Welsing, M Kedves, A Hamar, ... Annals of the rheumatic diseases 80 (1), 31-35	2021
Combating physical inactivity during the COVID-19 pandemic AJ Pinto, DW Dunstan, N Owen, E Bonfá, B Gualano Nature Reviews Rheumatology 16 (7), 347-348	2020
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity D Mrak, S Tobudic, M Koblischke, M Graninger, H Radner, D Sieghart, ... Annals of the rheumatic diseases 80 (10), 1345-1350	2021
Management of rheumatoid arthritis: an overview AF Radu, SG Bungau Cells 10 (11), 2857	2021
The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19 C Perricone, P Triggianese, E Bartoloni, G Cafaro, AF Bonifacio, R Bursi, ... Journal of Autoimmunity 111, 102468	2020
Macrophages: the good, the bad, and the gluttony EA Ross, A Devitt, JR Johnson Frontiers in immunology 12, 708186	2021
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement P Nash, A Kerschbaumer, T Dörner, M Dougados, RM Fleischmann, ... Annals of the rheumatic diseases 80 (1), 71-87	2021
JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data R Harrington, SA Al Nokhatha, R Conway Journal of inflammation research, 519-531	2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18	2023
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach Y Tanaka, Y Luo, JJ O’Shea, S Nakayamada Nature Reviews Rheumatology 18 (3), 133-145	2022
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial B Combe, A Kivitz, Y Tanaka, D van Der Heijde, JA Simon, HSB Baraf, ... Annals of the rheumatic diseases 80 (7), 848-858	2021
COVID‐19 pneumonia treated with sarilumab: a clinical series of eight patients M Benucci, G Giannasi, P Cecchini, FL Gobbi, A Damiani, V Grossi, ... Journal of medical virology 92 (11), 2368	2020
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy L Quartuccio, F Valent, E Pasut, C Tascini, S De Vita Joint bone spine 87 (5), 439-443	2020
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future J Angelini, R Talotta, R Roncato, G Fornasier, G Barbiero, L Dal Cin, ... Biomolecules 10 (7), 1002	2020
Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: a randomized clinical trial SW Syversen, GL Goll, KK Jørgensen, Ø Sandanger, J Sexton, IC Olsen, ... Jama 325 (17), 1744-1754	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。